Updated Jan 16, 2018

The use of a permanent make-up (or tattoo) device to target drug delivery against cutaneous leishmaniasis.

https://www.mcgill.ca/

The innovation has no owner

Claim it

The proposed idea is to use a permanent make-up device to target intra-dermal administration of an anti-cutaneous leishmaniasis therapy and deliver and concentrate the drug in professional phagocytes.
How does your innovation work?
The proposed idea is to use a permanent make-up (or tattoo) device, a proven technology of the cosmetic sector, to a) target intra-dermal administration of an ...
SEE ALL
The proposed idea is to use a permanent make-up device to target intra-dermal administration of an anti-cutaneous leishmaniasis therapy and deliver and concentrate the drug in professional phagocytes.
How does your innovation work?
The proposed idea is to use a permanent make-up (or tattoo) device, a proven technology of the cosmetic sector, to a) target intra-dermal administration of an anti-cutaneous leishmaniasis therapy, and b) deliver and concentrate the drug in professional phagocytes, the exclusive replicative niche of the leishmania parasites.
SEE LESS

Stage 2: Research & Development

Registered in Canadain Canada

Focus Areas:

Health, Prevention & Vaccination, Human Centered Design and 1 MoreSEE ALL

Health, Prevention & Vaccination, Human Centered Design and TechnologySEE LESS

Implemented In:

Iran

IranSEE LESS

1
Country Implemented In
Verified Funding
?

Milestone

Jun 2011
Date Unknown
Created
Date Unknown
New Country Implemented In
Iran